Keynote: The Evolution of PK/PD Models for Clinical Practice and Drug Development

Monday, November 10, 2025

1:30 PM - 2:30 PM CT

Location:225 CD

Keynote Speaker(s)

Murray Ducharme, DPH, PharmD, FCCP, FCP

President and CEO
Learn & Confirm, Inc.
Montreal, Quebec, Canada

Moderator(s)

Pankajini Mallick, PhD (she/her/hers)

Principal Scientist
Neurocrine
San Diego, California

Join me for a personal and historical journey through the evolution of PKPD in clinical practice and drug development. This presentation will explore how individual and population PK modeling, Therapeutic Drug Monitoring, simulations, and Artificial Intelligence have impacted the field. Discover what are arguably the most important breakthroughs of the last 30 years and their impact on advancing drug development and patient care.

Learning Objectives:

Explain the evolution of pharmacokinetic and pharmacodynamic (PKPD) modeling in clinical practice and drug development.
Identify key breakthroughs in PKPD, and their impact on advancing drug development and outcomes.
Discuss how the integration of clinical, mathematical, computer, and regulatory sciences are continually influencing drug development processes and patient care.